Literature DB >> 9581679

pp60c-src activation in hepatocellular carcinoma of humans and LEC rats.

T Masaki1, M Okada, Y Shiratori, W Rengifo, K Matsumoto, S Maeda, N Kato, F Kanai, Y Komatsu, M Nishioka, M Omata.   

Abstract

For the related Src kinases, a close correlation exists between elevated tyrosine kinase activity and cell transformation. However, the involvement of pp60c-src in hepatocellular carcinoma (HCC) remains obscure. The aim of this study was to evaluate whether pp60c-src tyrosine kinase activity is elevated in HCC. We analyzed the kinase activity of pp60c-src in normal liver tissue, chronic hepatitis liver tissue, and tumorous and adjacent nontumorous portions of HCC tissue from patients and Long-Evans cinnamon (LEC) rats that are known to develop liver cancer spontaneously. The kinase activity of pp60c-src was rarely detected in the normal human liver tissue and chronic hepatitis liver tissue, but it was elevated in tumorous and nontumorous portions of HCC tissue. Furthermore, the kinase activity of pp60c-src was significantly elevated in tumorous tissues compared with nontumorous tissues. The kinase activity of pp60c-src was also higher in poorly differentiated HCC. In addition, the kinase activity of pp60c-src increased proportionately with the development of HCC of LEC rats. Our results suggest that activation of the protooncogene product pp60c-src may play an important role in the malignant transformation of hepatocytes in human and LEC rats, and that it may be closely related to the histopathological grading of human HCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581679     DOI: 10.1002/hep.510270511

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Authors:  Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

3.  β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.

Authors:  Sharada Mokkapati; Katharina Niopek; Le Huang; Kegan J Cunniff; E Cristy Ruteshouser; Mark deCaestecker; Milton J Finegold; Vicki Huff
Journal:  Cancer Res       Date:  2014-05-21       Impact factor: 12.701

4.  Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients.

Authors:  Ran Zhao; Yiqi Wu; Tianzhen Wang; Yuhua Zhang; Dan Kong; Lei Zhang; Xiaobo Li; Guangyu Wang; Yinji Jin; Xiaoming Jin; Fengmin Zhang
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

5.  Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular Carcinoma.

Authors:  Pierpaolo Calandro; Giulia Iovenitti; Claudio Zamperini; Francesca Candita; Elena Dreassi; Mario Chiariello; Adriano Angelucci; Silvia Schenone; Maurizio Botta; Arianna Mancini
Journal:  ACS Med Chem Lett       Date:  2018-05-07       Impact factor: 4.345

6.  Amplification of MPZL1/PZR gene in hepatocellular carcinoma.

Authors:  Yao-Tsung Yeh; Hong-Ying Dai; Ching-Yen Chien
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

7.  Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?

Authors:  Beatrix Elsberger; Bingchao A Tan; Thomas J Mitchell; Sylvia B F Brown; Elizabeth A Mallon; Sian M Tovey; Timothy G Cooke; Valerie G Brunton; Joanne Edwards
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

8.  Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.

Authors:  Grace M Lau; Gillian M Lau; Guo-Liang Yu; Irwin H Gelman; Alan Gutowski; David Hangauer; Jane W S Fang
Journal:  Dig Dis Sci       Date:  2008-11-01       Impact factor: 3.199

Review 9.  Dysregulation of apoptosis in hepatocellular carcinoma cells.

Authors:  Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

10.  The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.

Authors:  T Qayyum; G Fyffe; M Duncan; P A McArdle; M Hilmy; C Orange; G Halbert; M Seywright; P G Horgan; M A Underwood; J Edwards
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.